AMA Unveils New Policy to Boost Transparency in Clinical AI Tools

As augmented intelligence tools become more integrated into healthcare, the American Medical Association (AMA) has introduced a new policy to promote transparency and trust in these technologies. Announced during its Annual Meeting, the policy emphasizes the importance of explainable clinical AI tools that provide accessible safety and efficacy data, enabling healthcare professionals to make informed decisions regarding patient care. It also calls for increased oversight and regulation of AI algorithms through independent evaluations, ensuring that their explainability supplements traditional methods of validating safety and efficacy. Dr. Alexander Ding, from the AMA Board, underscored the necessity of transparency for physicians to confidently utilize these tools in clinical settings.

Opens on AMA